2 April 2019 - A federal judge in Washington, D.C. has ruled that an association of oncologists cannot pursue a lawsuit challenging a 2% cut in reimbursements by Medicare for medications administered by health care providers including cancer drugs.
U.S. District Judge Tanya Chutkan on Sunday dismissed Washington-based Community Oncology Alliance’s lawsuit, saying the law governing how Medicare Part B drug reimbursement rates are calculated precludes judicial review of them.